Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 74, Issue 12, 2003, Pages 1615-1620

  Szolnoki, Z ^a   Somogyvari F ^a   Kondacs, A ^a   Szabo M ^a   Fodor, L ^a   Bene, J ^b   Melegh, B ^b  

^a Pandy Kalman County Hospital   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN E4; BLOOD CLOTTING FACTOR 5 LEIDEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALCOHOL ABUSE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DNA DETERMINATION; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; HUMAN CELL; HYPERTENSION; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIFACTORIAL GENETIC DISORDER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING;

AGED; ALCOHOL DRINKING; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIABETES COMPLICATIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUTATION; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 0348012911     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.12.1615     Document Type: Article

References (53)

1. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain 2000;123:1784-812.
2. Elbaz A, Amarenco P. Genetic susceptibility and ischemic stroke. Curr Opin Neurol 1999;12:47-55.
3. Szolnoki Z, Somogyvári F, Kondacs A, et al. Evaluation of the roles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ischaemic stroke. J Neurol 2001;248:756-61.
4. Szolnoki Z, Somogyvári F, Szabó M, et al. A clustering of unfavourable common genetic mutations in stroke cases. Acta Neurol Scand 2000;102:124-8.
5. Szolnoki Z, Somogyvári F, Szólics M, et al. Common genetic mutations as possible aetiological factors in stroke. Eur Neurol 2001;45:119-20.
6. Szolnoki Z, Somogyvári F, Kondacs A, et al. Evaluation of the roles of common genetic mutations in leukoaraiosis. Acta Neurol Scand 2001;104:281-7.
7. Glueck CJ, Fontaine RN, Wang P. Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischaemic optic neuropathy and ischaemic stroke. Thromb Haemosr 2001;85:256-9.
8. Huisman MV, Rosendaal F. Thrombophilia. Curr Opin Hematol 1999;6:291-7.
9. Appleby RD, Olds RJ. The inherited basis of venous thrombosis. Pathology 1997;29:341-7.
10. Catto A, Carter A, Ireland H, et al. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol 1995;15:783-5.
11. Chimowitz M, Mansbach H, Schmaier A. Factor V mutation and cryptogenic stroke in the young. Stroke 1996;27:188.
12. De Lucia D, Papa ML, Ammendola F, et al. Association of elevated level of prothrombin fragment 1+2 and Arg506 to Gin mutation in patients with a history of ischemic stroke. J Neurosurg Sci 1999;43:45-50.
13. Eskandari MK, Bontempo FA, Hassett AC, et al. Arterial thromboembolic events in patients with the factor V Leiden mutation. Am J Surg 1998;176:122-5.
14. Gaustadnes M, Rudiger N, Moller J, et al. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients. Blood Coagul Fibrinolysis 1999;10:251-9.
15. Stolz E, Kemkes-Matthes B, Potzsch B, et al. Screening for thrombophilic risk factors among 25 german patients with cerebral venous thrombosis. Acta Neurol Scand 2000;102:31-6.
16. Lalouschek W, Aull S, Serles W, et al. C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study. Thromb Res 1999;93:61-9.
17. Longstreth Jr WT, Rosendaal FR, Siscovick DS, et al. Risk of stroke in young women and two prothrombic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke 1998;29:577-80.
18. Ludemann P, Nabavi DG, Junker R, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case control study of 55 patients. Stroke 1998;29:2507-10.
19. McColl MD, Chalmers EA, Thomas A, et al. Factor V Leiden, prothrombin 20210G A and the MTHFRC677T mutations in childhood stroke. Thromb Haemost 1999;81:690-4.
20. Meschia JF, Biller J, Witt T, et al. Is hormone replacement a risk factor for ischemic stroke in women with factor V Leiden mutation? Arch Neurol 1998;55:1137-9.
21. Nabavi DG, Junker R, Wolff E, et al. Prevalence of factor V Leiden mutation in young adults with cerebral ischemia. A case-control study on 225 patients. J Neurol 1998;245:653-8.
22. Notsu Y, Nabika T, Park HY, et al. Evaluation of genetic risk factors for silent brain infarction. Stroke 1999;30:1881-6.
23. Orlandi G, Pellegrinetti A, Fioretti C, et al. Factor V Leiden mutation in a case with ischemic stroke: which relationship? Angiology 1998;49:79-82.
24. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
25. Ridker PM, Glynn RJ, Miletich JP, et al. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med 1997;126:528-31.
26. Zenz W, Bodo Z, Plotho J, et al. Factor V Leiden and prothrombin gene G20210A variant in children with ischemic stroke. Thromb Haemost 1998;80:763-6.
27. Chaturvedi S, Dzieczkowski JS. Protein S deficiency, activated protein C resistance and sticky platelet syndrome in a young woman with bilateral strokes. Cerebrovasc Dis 1999;9:127-30.
28. Weih M, Vetter B, Castell S, et al. Hereditary thrombophilia in cerebral venous thrombosis. Cerebrovasc Dis 2000;10:161-2.
29. Kontula K, Ylikorkala A, Miettinen H, et al. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995;73:558-60.
30. Agerholm-Larsen B, Tybjaerg-Hansen A, Frikke-Schmidt R, et al. ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease. Ann Intern Med 1997;127:346-55.
31. Doi Y, Yoshinari M, Yoshizumi H, et al. Polymorphism of the angiotensin-converting enzyme (ACE) gene in patients with thrombotic brain infarction. Atherosclerosis 1997;132:145-50.
32. Kostulas K, Huang WX, Crisby M, et al. An angiotensin-converting enzyme gene polymorphism suggests a genetic distinction between ischaemic stroke and carotid stenosis. Eur J Clin Invest 1999;29:478-83.
33. Markus HS, Barley J, Lunt R, et al. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995;26:1329-33.
34. Takami S, Imai Y, Katsuya T, et al. Gene polymorphism of the renin-angiotensin system associated with risk for lacunar infarction. The Ohasama study. Am J Hypertens 2000;13:121-7.
35. Ueda S, Weir CJ, Inglis GC, et al. Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke. J Hypertens 1995;13:1597-601.
36. Zee RY, Ridker PM, Stampfer MJ, et al. Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke. Circulation 1999;99:340-3.
37. Harmon DL, Doyle RM, Meleady R, et al. Genetic analysis of the thermolabile variant of 5, 10-methylenetetrafolate reductase as a risk factor for ischaemic stroke. Arterioscler Thromb Vasc Biol 1999;19:208-11.
38. Press RD, Beamer N, Evans A, et al. Role of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase in ischaemic stroke. Diagn Mol Pathol 1999;8:54-8.
39. Nakata Y, Katsuya T, Takami S, et al. Methylenetetrahydrofolate reductase gene polymorphism: relation to blood pressure and cerebrovascular disease. Am J Hypertens 1998;11:1019-23.
40. Salooja N, Catto A, Carter A, et al. Methylenetetrahydrofolate reductase C677T genotype and stroke. Clin Lab Haematol 1998;20:357-61.
41. De Stefano V, Chiusolo P, Paciaroni K, et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischaemic disease in young patients. Blood 1998;91:3562-5.
42. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, venous thrombosis in large cohort of US men. Circulation 1999;88:999-1004.
43. Perdro-Botet J, Senti M, Rubies-Prat J. Apolipaprotein E polymorphism and ischaemic cerebrovascular disease. Stroke 1994;25:521.
44. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E espilon 4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-2.
45. Topic E, Timundic AM, Ttefanovic M, et al. Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease. Clin Chem Lab Med 2001;39:346-50.
46. Chowdhury AH, Yokoyama T, Kokubo Y, et al. Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study. J Epidemiol 2001;11:131-8.
47. MacLeod MJ, De Lange RP, Breen G, et al. Lack of association between apolipoprotein E genotype and ischaemic stroke in a Scottish population. Eur J Clin Invest 2001;31:570-3. Report of WHO study group.
48. Group WS. Diabetes mellitus. Report of WHO study group. WHO Tech Rep Ser 1985;6:13-7.
49. Greengard JS, Xu X, Gandrile S, et al. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V. Thromb Res 1995;80:441-3.
50. Clark ZE, Bowen DJ, Whatley SD, et al. Genotyping method for methylenetetrahydrofalate reductase (C677T thermolabile variant) using heteroduplex technology. Clin Chem 1998;44:2360-2.
51. Danneberg J, Abbes AP, Bruggeman BJM, et al. A reliable genotyping of the g-20210-a mutation of coagulation factor II (prothrombin). Clin Chem 1998;44:349-50.
52. Crook R, Hardy J, Duff K. Single-day apolipoprotein E genotyping. J Neurosci Methods 1994;53:125-7.
53. Somogyvári F, Szolnoki Z, Márki-Zay J, et al. Real-time PCR assay with fluorescent hybridization probes for exact and rapid genotyping of the angiotensin-converting enzyme gene insertion/deletion polymorphism. Clin Chem 2001;47:1728-9.